HC Wainwright & Co. Reiterates Buy on Biohaven, Maintains $59 Price Target

Biohaven Pharmaceutical Holding Company Ltd. -1.33% Pre

Biohaven Pharmaceutical Holding Company Ltd.

BHVN

37.94

37.94

-1.33%

0.00% Pre

HC Wainwright & Co. analyst Douglas Tsao reiterates Biohaven (NYSE: BHVN) with a Buy and maintains $59 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via